Sign in

CIK 0001070494

  • Large accelerated filer

ACADIA PHARMACEUTICALS INC

Sign in to watch
Ticker
ACAD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
061376651
Phone
+1 858-558-2871
Business address
12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
  1. 4 Open-market sale EXEC VP, CFO AND CBO sold 40,000 shares at $11.06 ($442,400)
  2. 4 Open-market sale EVP, DEVELOPMENT AND CMO sold 58,584 shares at $7.69 ($450,365)
  3. 4 Open-market sale CEO sold 40,000 shares at $7.68 ($307,044)
  4. 4 Open-market sale VP AND GC sold 13,163 shares at $8.00 ($105,304)
  5. 4 Open-market sale EXEC VP, CFO AND CBO sold 40,000 shares at $7.68 ($307,084)
  6. 4 Option exercise Director acquired 4,500 shares (option exercise)
  7. 4 Derivatives Options or other derivatives
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 4 Gift CEO gave 7,500 shares (gift)
  13. 4 Option exercise EXEC VP, CFO AND CBO acquired 12,000 shares (option exercise)
  14. 4 Option exercise Director acquired 4,500 shares (option exercise)
  15. 4 Option exercise Director acquired 4,500 shares (option exercise)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market sale VP AND GC sold 20,602 shares at an average $6.06 ($124,845)
  18. 4 Open-market sale EXEC VP, CFO AND CBO sold 40,000 shares at an average $6.02 ($240,633)
  19. 4 Option exercise EXEC VP, CFO AND CBO acquired 7,500 shares (option exercise)
  20. 4 Gift CEO gave 23,333 shares (gift)

Page 25 of 35 · 686 filings